APPLIED DNA SCIENCES INC (APDN) Stock Income Statement
USA - NASDAQ:APDN - US03815U6073 - Common Stock
5.62 USD
+1.35 (+31.62%)
6.18 USD
+0.56 (+9.96%)
| TTM (2025-6-30) | 2024 (2024-9-30) | 2023 (2023-9-30) | 2022 (2022-9-30) | 2021 (2021-9-30) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 3.30M | 3.43M | 13.37M | 18.17M | 9.03M | |||
| Minority Interest Expense | 117.10K | 95.80K | 76.00K | 2.00K | -8.00K | |||
| Cost Of Goods | 1.99M | 2.41M | 7.83M | 13.12M | 4.10M | |||
| Gross Profit | 1.30M | 1.02M | 5.53M | 5.05M | 4.93M | |||
| Operating Expenses | 14.70M | 15.04M | 16.49M | 19.02M | 17.22M | |||
| Research and Development | 3.46M | 3.59M | 3.73M | 3.93M | 3.77M | |||
| Selling, General, and Administrative Expenses | 11.23M | 11.45M | 12.75M | 15.10M | 12.61M | |||
| Operating Income | -13.39M | -14.02M | -10.95M | -13.97M | -12.29M | |||
| Interest Income/Expense | 263.30K | 176.30K | 75.00K | 7.00K | 14.00K | |||
| Other Income/Expense | 161.30K | 6.76M | 855.00K | 5.69M | -244.00K | |||
| Non Recurring Items | N/A | N/A | N/A | 0.00 | -1.76M | |||
| Income Before Taxes | -12.97M | -7.09M | -10.02M | -8.27M | -14.28M | |||
| Income Tax | N/A | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Net Income | -67.51M | -7.23M | -9.95M | -8.38M | -14.29M | |||
| EBITDA | -13.06M | -13.33M | -9.59M | -12.68M | -11.45M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -920.15 | -1.37K | -11.43K | -13.96K | -31.06K | |||
| Non GAAP EPS | -924.25 | -5.22K | -11.25K | -15.00K | -29.28K | |||
| Statistics | ||||||||
| Gross Profit Margin | 39.57% | 29.64% | 41.39% | 27.82% | 54.59% | |||
| Profit Margin | -2047.38% | -210.57% | -74.41% | -46.11% | -158.24% | |||
| Operating Profit Margin | -406.10% | -408.72% | -81.94% | -76.89% | -136.17% | |||
All data in USD